Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Select Advanced Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01760525
What this trial is testing

A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors

Who this might be right for
Solid Tumor With p53 Wild Type Status
Novartis Pharmaceuticals 51
Early research (Phase 1)Looking for participantsNCT07593820
What this trial is testing

A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.

Who this might be right for
Metastatic Gastric CancerMetastatic Breast CancerEndometrial Cancer Metastatic
Vall d'Hebron Institute of Oncology 15
Large-scale testing (Phase 3)Ended earlyNCT00003056
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaGraft Versus Host Disease
Baxalta now part of Shire 105
Testing effectiveness (Phase 2)Looking for participantsNCT07283731
What this trial is testing

Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma

Who this might be right for
Phase 2ZanzalintinibPembrolizumab+2 more
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698994
What this trial is testing

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Ependymal TumorRecurrent Ewing Sarcoma+33 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Active Not RecruitingNCT05544929
What this trial is testing

Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more
Novartis Pharmaceuticals 126
Testing effectiveness (Phase 2)Study completedNCT03802123
What this trial is testing

⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors

Who this might be right for
Positron-Emission TomographyMetastatic Solid Tumors
ImaginAb, Inc. 52
Testing effectiveness (Phase 2)Looking for participantsNCT04205968
What this trial is testing

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Who this might be right for
Metastatic Small Intestinal AdenocarcinomaStage III Small Intestinal Adenocarcinoma AJCC v8Stage IIIA Small Intestinal Adenocarcinoma AJCC v8+2 more
SWOG Cancer Research Network 94
Testing effectiveness (Phase 2)Looking for participantsNCT07605962
What this trial is testing

Phase 1/2 Study of UI-102 in Selected Advanced Cancers

Who this might be right for
Advanced Cancer
United Immunity, co., Ltd. 140
Testing effectiveness (Phase 2)Ended earlyNCT01133678
What this trial is testing

Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Head and Neck Cancer
University of Chicago 50
Testing effectiveness (Phase 2)Looking for participantsNCT04969315
What this trial is testing

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

Who this might be right for
Renal Cell CancerCastrate Resistant Prostate CancerNon Small Cell Lung Cancer+1 more
Portage Biotech 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262466
What this trial is testing

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Who this might be right for
Select Advanced Solid Tumors
Immunocore Ltd 410
Not applicableEnded earlyNCT06290856
What this trial is testing

Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

Who this might be right for
Metastatic Colorectal CancerPancreas AdenocarcinomaCholangiocarcinoma
Oslo University Hospital 16
Large-scale testing (Phase 3)Ended earlyNCT05134194
What this trial is testing

Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 1
Testing effectiveness (Phase 2)Looking for participantsNCT06427941
What this trial is testing

BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines 630
Large-scale testing (Phase 3)Not Yet RecruitingNCT07677293
What this trial is testing

Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1 Antibody Plus Chemotherapy as First-line Treatment for Advanced Gastric Cancer With Liver Metastases

Who this might be right for
Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Peking University 332
Large-scale testing (Phase 3)Study completedNCT01454934
What this trial is testing

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Eisai Inc. 540
Early research (Phase 1)Study completedNCT00292864
What this trial is testing

Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors

Who this might be right for
Tumors
Sunesis Pharmaceuticals 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105632
What this trial is testing

Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

Who this might be right for
Advanced or Metastatic Breast Cancer
Pfizer 333
Testing effectiveness (Phase 2)Looking for participantsNCT06598371
What this trial is testing

KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

Who this might be right for
Select Advanced Solid Tumors
M.D. Anderson Cancer Center 141
Next Page